All Posts By

Smartkarma Daily Briefs

Daily Brief Indonesia: Cisarua Mountain Dairy and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Primer: Cisarua Mountain Dairy (CMRY IJ) – Nov 2025


Primer: Cisarua Mountain Dairy (CMRY IJ) – Nov 2025

By αSK

  • Dominant Player in a High-Growth Market: Cisarua Mountain Dairy (CMRY) is a leading producer of premium dairy and consumer food products in Indonesia, a market poised for significant growth driven by a rising middle class, increasing health consciousness, and urbanization. The company holds a dominant market share, particularly in the yogurt category.
  • Robust Financial Performance and Strong Growth Track Record: CMRY has demonstrated an exceptional growth trajectory, with a 3-year revenue CAGR of 30.13% and a net income CAGR of 24.35%. This is underpinned by successful product innovation and expansion of its distribution network, leading to consistent margin expansion and strong free cash flow generation.
  • Strategic Focus on Innovation and Distribution Expansion: The company’s strategy centers on continuous product innovation in both its dairy (Cimory brand) and consumer foods (Kanzler brand) segments, coupled with an aggressive expansion of its distribution channels, including modern trade, general trade, and its unique direct-to-consumer ‘Miss Cimory’ network. This dual focus is expected to sustain its growth momentum and market leadership.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Microsoft Corp, Expand Energy, Zebra Technologies Corp, Xylem Inc, NCR Atleos , Advanced Micro Devices, Teradyne Inc, Neurocrine Biosciences, Veralto , Exzeo Group and more

By | Daily Briefs, United States

In today’s briefing:

  • Microsoft’s OpenAI Conundrum
  • Expand Energy Eyes Western Haynesville Boom – Could This Be Its Next Big Jackpot?
  • Zebra Technologies: How Its RFID Empire Is Taking Over Multiple Industries!
  • Xylem Teams Up with Amazon: How Smart Water Tech Is Reshaping Global Cities!
  • NCR Atleos – Growth at a Value Price
  • AMD: Management Expects Revenue Re-Acceleration from 2H26 with MI400 Launch
  • Teradyne Inc.: Strategic Positioning in the Memory Market to Enhance Market Share & Revenue In Memory Testing Segment!
  • Neurocrine Biosciences Doubles Down on CRENESSITY – Can This Strategy Dominate the CAH Market?
  • Veralto’s Data Center Revolution – How Water Tech Became the Next Big Thing in AI!
  • Exzeo Group Inc. (XZO): IPO Opens Flat for the HCI Spin-Off Insurtech


Microsoft’s OpenAI Conundrum

By William Keating

  • In Q126, Microsoft recorded $4.1 billion in net losses from investments in OpenAI, up from $688 million in the year ago quarter.
  • The newly updated partnership between Microsoft and OpenAI has many clauses contingent on when (not if) AGI gets declared. Since AGI has no actual definition, an expert panel will decide. 
  • Sam Altman dreams of an OpenAI IPO so that detractors can be lured into shorting the stock and getting burned in the process. Revenue growth is a touchy subject, apparently

Expand Energy Eyes Western Haynesville Boom – Could This Be Its Next Big Jackpot?

By Baptista Research

  • Expand Energy’s latest quarterly results highlight both positive strides and challenges within the company’s operations and strategic outlook.
  • The company has pursued capital efficiency, managing to reduce costs significantly while increasing production, particularly in the Haynesville region.
  • Expand Energy has demonstrated an impressive cost reduction in well expenses by over 25% and outperformed peers with year-to-date costs 30% lower, thanks to optimized development and completion designs.

Zebra Technologies: How Its RFID Empire Is Taking Over Multiple Industries!

By Baptista Research

  • Zebra Technologies reported its third-quarter 2025 results, surpassing its initial outlook.
  • The company posted $1.3 billion in sales, representing a year-on-year increase of 5%.
  • Adjusted EBITDA margin improved slightly by 20 basis points to 21.6%, and non-GAAP diluted EPS rose by 11% to $3.88.

Xylem Teams Up with Amazon: How Smart Water Tech Is Reshaping Global Cities!

By Baptista Research

  • Xylem Inc., a leading global water technology company, reported solid results in the third quarter of 2025.
  • The company demonstrated strong financial performance with notable growth across its segments and has adjusted its full-year outlook upwards due to ongoing robust demand and efficient execution of its strategic initiatives.
  • Positively, Xylem registered an increase in revenue across all its segments, with a marked double-digit growth in both Measurement and Control Solutions (MCS) and Water Solutions and Services (WSS).

NCR Atleos – Growth at a Value Price

By Richard Howe

  • NCR Atleos (NATL) is a 2023 spin-off that is focused on the ATM market.
  • It is benefiting from banks outsourcing their ATM operations which is driving high margin growth (ATMaaS revenue up 32% and backlog up 105% in the last quarter).
  • The company is going to grow earnings at a 20% rate for the foreseeable future. 

AMD: Management Expects Revenue Re-Acceleration from 2H26 with MI400 Launch

By Nicolas Baratte

  • Good 3Q25, good 4Q guidance, optimism that the Server CPU market is growing faster, new GPU MI400 (2H26) will re-accelerate growth. Plus some price increase or higher ASP. Not controversial.
  • More controversial is Consensus expecting OP margin to jump from 24% (2025) to 31% (2027). There will be leverage as Data Center AI revenues grow – but it looks optimistic.
  • Valuations are elevated (41x 2026 EPS) for good reasons 1) Server share gains 2) rapid AI growth 3) higher ASP. After a vertical rally, the share price needs some room.

Teradyne Inc.: Strategic Positioning in the Memory Market to Enhance Market Share & Revenue In Memory Testing Segment!

By Baptista Research

  • Teradyne Inc. reported robust financial results for the third quarter of 2025, with a notable revenue growth of 18% and a significant increase in non-GAAP EPS by 49%.
  • This performance was primarily driven by heightened demand for semiconductor tests related to AI applications.
  • The UltraFLEXplus platform, which is tailored for high-performance processors and networking devices, has seen increased use due to the complexities of AI devices, indicating the strategic advantage of Teradyne’s focused R&D investments.

Neurocrine Biosciences Doubles Down on CRENESSITY – Can This Strategy Dominate the CAH Market?

By Baptista Research

  • In the third quarter of 2025, Neurocrine Biosciences reported robust financial and operational performance.
  • The period was marked by $790 million in net product sales, a 28% year-over-year increase, driven by their flagship drugs INGREZZA and CRENESSITY.
  • INGREZZA, used for treating tardive dyskinesia and Huntington’s chorea, saw continued growth attributed to recent expansions of the sales force and improved patient access, resulting in record new patient starts and prescriptions.

Veralto’s Data Center Revolution – How Water Tech Became the Next Big Thing in AI!

By Baptista Research

  • Veralto Corporation delivered a robust yet nuanced performance in the third quarter of 2025, reflecting significant progress across its key business segments amidst a continually evolving macroeconomic landscape.
  • The company reported a 5.1% increase in core sales and an 11% growth in adjusted earnings per share, propelled by strong execution within its Water Quality and Product Quality & Integrity (PQI) sectors.
  • Despite navigating challenges such as global trade policy shifts, Veralto raised its full-year adjusted earnings per share guidance, showcasing resilience and adaptability.

Exzeo Group Inc. (XZO): IPO Opens Flat for the HCI Spin-Off Insurtech

By IPO Boutique

  • Exzeo priced mid-range at $21.00 and traded flat, signaling a disciplined and stable market entrance.
  • Profitable, zero-debt insurtech spin-off from HCI boasting 50%+ EBITDA margins and $195M ARR.
  • Expanding beyond 13 states into major markets; poised for sustainable, high-margin growth under proven leadership.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Pony AI, All Winner Technology, BYD, China Medical System, Ningbo Joyson Electronic, Milian Technology, Impro Precision Industries, Car Inc and more

By | China, Daily Briefs

In today’s briefing:

  • Pony.AI Hong Kong Public Offering Valuation Analysis
  • PonyAI and WeRide Secondary HK Trading – Weakish Demand, WeRide Did Better but Trading Lower
  • CES China Semiconductor Chips Index Rebalance Preview: One Change Likely in Dec
  • BYD (1211 HK) Tactical Outlook: Still Downtrending, But OVERSOLD
  • China Medical Systems Holdings Limited Initiating Coverage
  • Ningbo Joyson IPO Trading: Tight Premium and Mediocre Insti Demand
  • Milian Technology IPO Valuation Analysis: A Dating App Company May Seek Unicorn Valuation In HK IPO
  • Primer: Impro Precision Industries (1286 HK) – Nov 2025
  • Primer: VNET Group (VNET US) – Nov 2025
  • Primer: Car Inc (699 HK) – Nov 2025


Pony.AI Hong Kong Public Offering Valuation Analysis

By Douglas Kim

  • Pony.ai has finalized the Hong Kong public offering price at HK$139 per share and it expects to raise HK$6.71 billion (US$860 million) from its planned secondary listing in Hong Kong. 
  • Our base case valuation of Pony.Ai is HK$178.2 per share over the next 6-12 months, which represents 28% higher than the Hong Kong public offering price. 
  • Given the solid upside, we have a Positive View of Pony.ai. Despite our Positive view, there have been increasing concerns about the overstretched valuations of major AI/tech related companies globally.

PonyAI and WeRide Secondary HK Trading – Weakish Demand, WeRide Did Better but Trading Lower

By Sumeet Singh

  • Pony AI (PONY US) raised around US$860m and WeRide (WRD US) raised around US$310m in their HK Secondary offering.
  • We have looked at the deal dynamics in our previous note.
  • In this note, we talk about the trading dynamics for the two deals.

CES China Semiconductor Chips Index Rebalance Preview: One Change Likely in Dec

By Brian Freitas


BYD (1211 HK) Tactical Outlook: Still Downtrending, But OVERSOLD

By Nico Rosti

  • BYD (1211 HK) does not seem ready yet to reverse its downtrend, sentiment is still negative (not too negative), Q3 revenues decreased (no surprise, as recently noted by Ming Lu).
  • BYD is short-term OVERSOLD, this is a tactical WEEKLY view presenting an actionable opportunity with a 1-3 week trade horizon (probably a 2 weeks rebound, maximum).
  • Our quantitative models say the stock will not correct for more than 3 weeks when this pattern is encountered (the stock is currently in its second consecutive week down).

China Medical Systems Holdings Limited Initiating Coverage

By Impact Capital Asset Management

  • The company’s founder Mr. Lam Kong serves as Chairman, Chief Executive and President.
  • The other key management personnel are Ms. Chen Yanling who is the Executive Director and CFO.
  • The company’s six -member board comprises two executives, one non -executive, and three independent non -executive directors. Committees cover Audit, Remuneration, Nomination, and ESG, with INEDs forming the majority on committees.

Ningbo Joyson IPO Trading: Tight Premium and Mediocre Insti Demand

By Nicholas Tan

  • Ningbo Joyson Electronic (600699 CH) is looking to raise up to US$471m in its upcoming Hong Kong IPO.
  • NBJ, is an intelligent automotive technology solution provider, offering advanced products and solutions across the auto part industry’s key areas including automotive electronics and automotive safety.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Milian Technology IPO Valuation Analysis: A Dating App Company May Seek Unicorn Valuation In HK IPO

By Andrei Zakharov

  • Milian Technology files for Hong Kong IPO and seeks fresh capital for further expanding its global presence and accelerating overseas market penetration.  
  • Xiaomi backed online social networking platform company is one of the fastest growing marriage and dating platforms in China, reaching RMB2,373m revenue in 2024, up ~129% YoY.
  • I expect Milian Technology may seek unicorn valuation in upcoming HK IPO as growth is exceptionally high and profitability improved.

Primer: Impro Precision Industries (1286 HK) – Nov 2025

By αSK

  • Diversified End-Market Exposure Mitigates Cyclicality: Impro serves a wide range of industries, including automotive, high-horsepower engines, aerospace, medical, and construction. This diversification helps to cushion the impact of downturns in any single sector. Recent strength in the aerospace and high-horsepower engine (driven by AI data center demand) segments has offset weakness in others.
  • Strong Financial Performance and Shareholder Returns: The company has demonstrated a solid growth track record, particularly over the last three years, with an 18.95% CAGR in net income and a 40.46% CAGR in free cash flow. This financial strength supports a consistent and attractive dividend yield, which stood at 8.2% in the most recent fiscal year.
  • Strategic Global Footprint and ‘One-Stop Shop’ Capabilities: With manufacturing facilities in China, Mexico, Turkey, and Europe, Impro is well-positioned to serve its global customer base and mitigate geopolitical risks. Its comprehensive service offering, from design and casting to precision machining and surface treatment, provides a key competitive advantage and deepens customer relationships.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: VNET Group (VNET US) – Nov 2025

By αSK

  • VNET Group is a leading carrier- and cloud-neutral data center services provider in China, poised to benefit from the country’s growing digital economy, particularly the demand for cloud computing and artificial intelligence (AI) infrastructure.
  • The company’s ‘dual-core’ strategy, catering to both wholesale hyperscale clients and retail enterprise customers, provides a diversified revenue stream and positions it to capture growth across different market segments.
  • While experiencing strong revenue growth, particularly in its wholesale segment driven by AI demand, VNET faces challenges related to profitability, high capital expenditures, and a significant debt load in a competitive market.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Car Inc (699 HK) – Nov 2025

By αSK

  • Privatization and Delisting: Car Inc. was privatized by private equity firm MBK Partners and delisted from the Hong Kong Stock Exchange on July 8, 2021, following a period of significant financial distress and corporate governance concerns. This report analyzes the company’s performance and position leading up to this event.
  • Market Leadership Under Pressure: Historically one of China’s largest car rental companies, Car Inc.’s market position was eroded by intense competition, the negative impact of the COVID-19 pandemic, and its association with the Luckin Coffee accounting scandal through its founder, Charles Lu Zhengyao.
  • Challenging Financial Trajectory: The company exhibited a significant deterioration in financial performance, with declining revenue, negative margins, and substantial net losses in the period leading up to its privatization. This was a stark reversal from its previously profitable operations.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Toyota Industries, Sumitomo Chemical, Mandom Corp, D.Western Therapeutics Institute Inc., Marubun Corp, Intelligent Wave, Lib Work, Otsuka Holdings, Solvvy and more

By | Daily Briefs, Japan

In today’s briefing:

  • Toyota Industries (6201 JP): Market Movements Support the Case of a Higher Offer
  • StubWorld: Sumitomo Chemical/Sumitomo Pharma, Hyundai Motor/ Kia Corp, Ecopro Co/Ecopro BM
  • [Japan Activism] Mandom (4917 JP) – Murakami at 20% and Mandom Offers A Sweet Poison Pill
  • News Flash: D. Western Therapeutics Institute (4576 JP) – November 5, 2025
  • Marubun Corp (7537 JP): 1H FY03/26 flash update
  • Intelligent Wave (4847 JP): Q1 FY06/26 flash update
  • (05 Nov 2025) Lib Work<1431> — Fisco Company Research
  • Otsuka Holdings (4578 JP): Rexulti, Abilify Drive 2025 Guidance Upward, All Eyes on Sibeprenlimab
  • (5 Nov 2025) Solvvy Inc.<7320> — Fisco Company Research
  • (05 Nov 2025) Solvvy (English Version) <7320> — Fisco Company Research


Toyota Industries (6201 JP): Market Movements Support the Case of a Higher Offer

By Arun George

  • Last month, nearly two dozen global asset managers, through ACGA, submitted a joint letter to the boards of Toyota Industries (6201 JP) and Toyota Motor regarding the tender offer.
  • The letter outlined five issues, which distilled down to concerns about a low-balled offer. Their cause is increasingly supported by market movements, which support the case for the bump.
  • Recent activism against several low-balled tenders signals that TICO, despite its size, is not immune. My SoTP valuation is JPY19,607, which is 20.3% above the offer price.

StubWorld: Sumitomo Chemical/Sumitomo Pharma, Hyundai Motor/ Kia Corp, Ecopro Co/Ecopro BM

By David Blennerhassett

  • For a change of pace, this insight briefly canvasses a clutch of Holdco’s trading at extreme levels, in both “set-up” and “unwind” territory.
  • Preceding the chart/table-heavy insight are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

[Japan Activism] Mandom (4917 JP) – Murakami at 20% and Mandom Offers A Sweet Poison Pill

By Travis Lundy

  • Mandom Corp (4917 JP) yesterday decided to launch a question-response effort for the Murakami-san Group ownership of Mandom shares up to and above 20%. This is a Poison Pill precursor.
  • There’s a drawn out set of questions, answers, etc, at the end of which, the Independent Committee will decide that Murakami is a Bad Person and the Poison Pill proceeds.
  • Murakami Group is apparently now over 20%. That’s a little tricky. But this looks like a Good Poison Pill. 

News Flash: D. Western Therapeutics Institute (4576 JP) – November 5, 2025

By Sessa Investment Research

  • DWTI announced after the close on 11/4 that 84.6% of the Series 13 Share Acquisition Rights (with exercise price adjustment clause) issued on July 31, 2025, have already been exercised in just three months since the issue (see table below). In other words, this leaves only 1.5mn shares, or 3.37% dilution remaining.
  • This marks a significant decline in selling pressure going forward, ahead of multiple expected share price catalysts, including 1) China launch of DW-1002 (Brilliant Blue G) for indication ILM staining as an aid for ophthalmic surgeries
  • 2) expected H1 2026 US launch of DW-5LBT (lidocaine patch, trade name Bondlido), as a treatment for neuropathic pain after shingles (post-herpetic neuralgia) in adults, and 3) announcement of details of the Japan development plan for new pipeline candidate H-1129 as a treatment for corneal and conjunctival diseases caused by immune disorders.

Marubun Corp (7537 JP): 1H FY03/26 flash update

By Shared Research

  • Net sales increased 4.2% YoY to JPY102.7bn, driven by strong semiconductor demand and space and defense equipment sales.
  • Operating income declined 37.5% YoY to JPY2.7bn due to lower gross profit from decreased agent transactions.
  • The company revised its FY03/26 forecast upward, with net sales projected at JPY210.0bn and operating income at JPY7.0bn.

Intelligent Wave (4847 JP): Q1 FY06/26 flash update

By Shared Research

  • Orders were JPY3.7bn (-34.3% YoY), order backlog JPY20.2bn (+8.6% YoY), sales JPY3.7bn (+5.7% YoY).
  • Operating profit was JPY206mn (-32.4% YoY), recurring profit JPY205mn (-32.7% YoY), net income JPY140mn (-32.9% YoY).
  • Sales increased 4.7% YoY in settlement domain, 22.8% in security domain, declined 13.2% in data communication.

(05 Nov 2025) Lib Work<1431> — Fisco Company Research

By FISCO

Key points (machine generated)

  • Lib Work is a HOUSE TECH COMPANY listed on the Fukuoka Stock Exchange Q-Board and Tokyo Stock Exchange Growth Market.
  • The company focuses on single-family homes, targeting first-time homebuyers in the Kyushu region and Tokyo through digital marketing.
  • Lib Work aims to innovate living with sustainability and technology, with a mission to change lives and create a sustainable future.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


Otsuka Holdings (4578 JP): Rexulti, Abilify Drive 2025 Guidance Upward, All Eyes on Sibeprenlimab

By Tina Banerjee

  • Otsuka Holdings (4578 JP) witnessed 5% revenue growth in 9M25, despite negative Fx impact. Mainstay pharmaceutical business (+6.5% YoY) drove revenue. Rexulti and Abilify remained strong.
  • Otsuka has revised 2025 guidance upwards on the back of steady progress in Pharma and Nutraceutical business. Overall, 2025 revenue is now expected to be ¥2420B (previous guidance ~ ¥2380B).
  • Otsuka’s two top selling drugs are steadily gaining traction, mainly in the U.S. Going ahead, the company is banking on new drugs like sibeprenlimab to further drive growth.

(5 Nov 2025) Solvvy Inc.<7320> — Fisco Company Research

By FISCO

Key points (machine generated)

  • Solvvy Inc. projects a 22.3% increase in net sales to ¥8,200 million and a 29.6% rise in operating profit to ¥2,100 million for FY6/26.
  • The company, which focuses on recurring revenue business consulting, has improved operational metrics despite a temporary net loss in FY6/25.
  • Solvvy plans to implement a progressive dividend policy, raising its dividend to ¥20.0 for FY6/26 to enhance shareholder returns.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


(05 Nov 2025) Solvvy (English Version) <7320> — Fisco Company Research

By FISCO

Key points (machine generated)

  • Solvvy Inc. is expected to experience significant growth in sales and profits in FY6/26, with plans for substantial dividend increases.
  • The company rebranded after acquiring MEDIA SEEK Inc. and now operates as a consulting firm addressing complex business issues.
  • Solvvy’s recurring revenue model includes three segments: Homeworth Tech (HWT) for housing services, ExtendTech (EXT) for renewable energy, and LifeTech (LFT) for system integration projects.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: JPX Margin Trading Weekly (Oct 31st): Advantest and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • JPX Margin Trading Weekly (Oct 31st): Advantest, Kobe Bussan, Disco, Mitsubishi UFJ Financial


JPX Margin Trading Weekly (Oct 31st): Advantest, Kobe Bussan, Disco, Mitsubishi UFJ Financial

By Ke Yan, CFA, FRM

  • We analyzed the changes in margin trading positions of JPX stocks as of Oct 31st. The aggregated net margin trading position is USD18,547m.
  • We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
  • We highlight net margin buy/sell changes in Advantest, Kobe Bussan, Disco, Mitsubishi UFJ Financial, Fujikura, Kioxia, Keyence, Tokyo Electron, IHI, Socionext, Advantest, Kobe Bussan, Disco, Mitsubishi Ufj Financial, Fujikura.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: With Many Parent/Founder-Family Companies and more

By | Daily Briefs, ESG

In today’s briefing:

  • With Many Parent/Founder-Family Companies, Effective Succession Planning Is a Difficult Task


With Many Parent/Founder-Family Companies, Effective Succession Planning Is a Difficult Task

By Aki Matsumoto

  • In the activities of Nomination Committee, the formulation of policies and criteria for appointing directors, CEOs, as well as the consideration of succession plans, are given low priority.
  • With major shareholders holding over 20% stakes present in half of companies, implementing process where the board accepts the nomination committee’s deliberated proposal on succession plans presents a significant hurdle.
  • The failure of nomination committees and independent outside directors, who constitute a majority in many companies, to fulfill their critical roles may be a significant hindrance to corporate growth.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Japan Morning Conection: Aggressive Dip Buying Sends Many Mainstay AI Names to New Highs and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Japan Morning Conection: Aggressive Dip Buying Sends Many Mainstay AI Names to New Highs
  • Ohayo Japan | Wall Street Rises On Tariff Rollback Hopes
  • Singapore Market Roundup (05-Nov-2025): DBS rates NTT DC REIT ‘buy’ with a 20% target increase.
  • Asia Real Estate Tracker (05-Nov-2025): Temasek considers merging Mapletree and Capitaland.
  • Consumer Monthly – WTR Consumer Stock Index Underperforms in October for the Third Straight Month
  • Hardman and Co Insight: Feeding the future
  • What’s New(s) in Amsterdam


Japan Morning Conection: Aggressive Dip Buying Sends Many Mainstay AI Names to New Highs

By Andrew Jackson

  • Memory prices surging WoW with wholesalers hoarding NAND and DRAM supplies as S/D remains tight.
  • Good read for connectivity/wire and cable names on the Lumentum and Coherent beat.
  • ARM beat setting a good tone for Softbank after its -17% 2-day drop.

Ohayo Japan | Wall Street Rises On Tariff Rollback Hopes

By Mark Chadwick

  • U.S. equities advanced as Supreme Court scepticism toward Trump tariffs fuelled hopes for rollbacks. Court questioning cantered on the president’s authority; traders trimmed bets that the tariffs would be upheld.
  • AMD rallied 2.5% after beating earnings expectations, lifting broader AI-related names including Broadcom (+2%) and Micron (+9%). But sentiment on AI mixed
  • In Japan: Another day full of earnings. Weak yen and potential rollback of tariffs likely a positive for Japan Autos and Industrials. 

Singapore Market Roundup (05-Nov-2025): DBS rates NTT DC REIT ‘buy’ with a 20% target increase.

By Singapore Market Roundup

  • DBS initiates coverage of NTT DC REIT as ‘buy’ with a 20% target rise.
  • OCBC lowers First REIT’s fair value due to ongoing FX impact.           
  • AIMS APAC REIT reports 1.1% increase in DPU for 1HFY2026.

Asia Real Estate Tracker (05-Nov-2025): Temasek considers merging Mapletree and Capitaland.

By Asia Real Estate Tracker

  • Temasek is considering a merger of Mapletree and Capitaland to create a $150 billion fund manager.
  • Ex-Blackstone and Partners Group have raised $1.1 billion for real estate secondaries in Asia-Pacific.
  • Wee Hur and Aravest have purchased Singapore’s Hotel Miramar for $123 million and a Brisbane office tower.

Consumer Monthly – WTR Consumer Stock Index Underperforms in October for the Third Straight Month

By Water Tower Research

  • The WTR Consumer Index declined 4.1% in October, lagging the S&P SmallCap 600, which was down only 0.9%, for the third straight month.
  • Our index underperformed in October despite showing relative earnings outperformance.
  • The WTR Consumer Index’s prospective 12-month earnings increased 1.6% versus a 0.6% decline for the S&P SmallCap 600.

Hardman and Co Insight: Feeding the future

By Hardman & Co

  • The global food system has been, and continues to, undergo a structural transformation driven by population growth, climate change and the rise of a larger, wealthier global population.
  • The global middle-class population is projected to increase from 4.1bn currently to just over 5bn by 2035.
  • By 2050, global food demand is expected to increase significantly as population rises and diets shift from staple grains to higher-value proteins and dairy products ‒ a change that exponentially increases the strain on land, water and feedstock systems worldwide.

What’s New(s) in Amsterdam

By The IDEA!

  • Ahold Delhaize’s results came in a bit better than expected, whereby especially the margin development in the US was the main (positive) surprise.
  • The margin in Europe was flat. Also impressive was the growth in online sales, both in Europe and the US.
  • The company reiterated its guidance for FY25 and announced a new EUR 1bn share buyback for 2026.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Pony.AI Hong Kong Public Offering Valuation Analysis and more

By | Daily Briefs, ECM

In today’s briefing:

  • Pony.AI Hong Kong Public Offering Valuation Analysis
  • PonyAI and WeRide Secondary HK Trading – Weakish Demand, WeRide Did Better but Trading Lower
  • Lendlease REIT Placement: DPU Accretive, past Offering Did Well
  • Groww IPO Review – India’s Largest & Fastest Growing Broker / Investment Platform.
  • The Pinkfong Company IPO Book Building Analysis
  • Physicswallah Pre-IPO – The Positives – Has Had a Dream Run
  • Ningbo Joyson IPO Trading: Tight Premium and Mediocre Insti Demand
  • Milian Technology IPO Valuation Analysis: A Dating App Company May Seek Unicorn Valuation In HK IPO
  • Exzeo Group Inc. (XZO): IPO Opens Flat for the HCI Spin-Off Insurtech
  • CNGR A/H Listing: PHIP Update and Thoughts on A/H Premium


Pony.AI Hong Kong Public Offering Valuation Analysis

By Douglas Kim

  • Pony.ai has finalized the Hong Kong public offering price at HK$139 per share and it expects to raise HK$6.71 billion (US$860 million) from its planned secondary listing in Hong Kong. 
  • Our base case valuation of Pony.Ai is HK$178.2 per share over the next 6-12 months, which represents 28% higher than the Hong Kong public offering price. 
  • Given the solid upside, we have a Positive View of Pony.ai. Despite our Positive view, there have been increasing concerns about the overstretched valuations of major AI/tech related companies globally.

PonyAI and WeRide Secondary HK Trading – Weakish Demand, WeRide Did Better but Trading Lower

By Sumeet Singh

  • Pony AI (PONY US) raised around US$860m and WeRide (WRD US) raised around US$310m in their HK Secondary offering.
  • We have looked at the deal dynamics in our previous note.
  • In this note, we talk about the trading dynamics for the two deals.

Lendlease REIT Placement: DPU Accretive, past Offering Did Well

By Nicholas Tan

  • Lendlease Global Commercial REIT (LREIT SP)  is looking to raise at least S$270m in a private placement, to fund acquisition of 70% interest in PLQ Mall.
  • Overall, this deal represents 44.2 days of ADV and 16.5% of shares outstanding.
  • In this note, we comment on the deal dynamics and run the deal through our ECM framework.

Groww IPO Review – India’s Largest & Fastest Growing Broker / Investment Platform.

By Himanshu Dugar

  • Groww is India’s largest stockbroker with 13mn active users. It is progressing towards a full-stack investment platform, expecting to cross-sell multiple financial products to over 18mn users on its platform.
  • It is aggressively expanding into lending (MTF, LAS) and has recently acquired ‘Fisdom’ to offer premiumised wealth solutions (AIF, insurance, tax-filing). It also owns Groww AMC, offering debt/equity/Fixed income products.
  • At 33 times FY25 earnings, IPO is priced reasonably considering its deep penetration in the market (customers from 98% Pincodes) and strong ARPU and profitability supported by decent retention metrics.

The Pinkfong Company IPO Book Building Analysis

By Douglas Kim

  • The Pinkfong Company successfully completed its IPO book building process. It finalized the IPO price at 38,000 won (high end of the IPO price range). 
  • A total of 2,300 domestic and international institutions participated in the book building process. The IPO competition ratio was 615.9 to 1.  
  • Our base case valuation of the Pinkfong Co is implied market cap of 671.4 billion won or target price of 46,369 won per share (over the next 6-12 months). 

Physicswallah Pre-IPO – The Positives – Has Had a Dream Run

By Sumeet Singh

  • Physicswallah is looking to raise about US$434m in its upcoming India IPO.
  • Physicswallah Ltd (PWL) offers test preparation courses for competitive examinations, and other courses such as for upskilling, across 13 education categories, including JEE, NEET, and UPSC, among others.
  • In this note, we talk about the positive aspects of the deal.

Ningbo Joyson IPO Trading: Tight Premium and Mediocre Insti Demand

By Nicholas Tan

  • Ningbo Joyson Electronic (600699 CH) is looking to raise up to US$471m in its upcoming Hong Kong IPO.
  • NBJ, is an intelligent automotive technology solution provider, offering advanced products and solutions across the auto part industry’s key areas including automotive electronics and automotive safety.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Milian Technology IPO Valuation Analysis: A Dating App Company May Seek Unicorn Valuation In HK IPO

By Andrei Zakharov

  • Milian Technology files for Hong Kong IPO and seeks fresh capital for further expanding its global presence and accelerating overseas market penetration.  
  • Xiaomi backed online social networking platform company is one of the fastest growing marriage and dating platforms in China, reaching RMB2,373m revenue in 2024, up ~129% YoY.
  • I expect Milian Technology may seek unicorn valuation in upcoming HK IPO as growth is exceptionally high and profitability improved.

Exzeo Group Inc. (XZO): IPO Opens Flat for the HCI Spin-Off Insurtech

By IPO Boutique

  • Exzeo priced mid-range at $21.00 and traded flat, signaling a disciplined and stable market entrance.
  • Profitable, zero-debt insurtech spin-off from HCI boasting 50%+ EBITDA margins and $195M ARR.
  • Expanding beyond 13 states into major markets; poised for sustainable, high-margin growth under proven leadership.

CNGR A/H Listing: PHIP Update and Thoughts on A/H Premium

By Nicholas Tan

  • CNGR Advanced Material (300919 CH), a Chinese battery-component producer, aims to raise up to US$700m in its H-share listing.
  • CNGR is a Chinese battery-component producer and a new energy materials company.
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Lucror Analytics – Morning Views Asia and more

By | Credit, Daily Briefs

In today’s briefing:

  • Lucror Analytics – Morning Views Asia
  • New World Development – Event Flash – Exchange Offers For All USD Perps And Bonds – Lucror Analytics


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Adani Energy Solutions, Adani Ports, Bharti Airtel
  • UST yields declined c. 3 bps across the curve yesterday as treasuries advanced amid a slump in risk assets, with the yield on the 2Y and 10Y UST falling to 3.58% and 4.09%, respectively.
  • Equities retreated, after several Wall Street chief executives expressed caution about stretched valuations.

New World Development – Event Flash – Exchange Offers For All USD Perps And Bonds – Lucror Analytics

By Leonard Law, CFA

  • We believe that New World Development’s (NWD) focus for the proposed exchange offers is to reduce its outstanding debt, mainly by restructuring the existing perps.
  • Hence, the exercise, if completed, would be credit positive for the company.
  • This would in turn support the prices of the existing straight bonds.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Toyota Industries (6201 JP): Market Movements Support the Case of a Higher Offer and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Toyota Industries (6201 JP): Market Movements Support the Case of a Higher Offer
  • StubWorld: Sumitomo Chemical/Sumitomo Pharma, Hyundai Motor/ Kia Corp, Ecopro Co/Ecopro BM
  • [Japan Activism] Mandom (4917 JP) – Murakami at 20% and Mandom Offers A Sweet Poison Pill
  • Reading the Latest Flow Patterns to Time a SK Square NAV Squeeze Trade
  • Physicswallah IPO: Index Inclusion Possibilities & Timing
  • Australia’s Big Banks: Options Flash Mixed Signals Ahead of Earnings
  • ABF – Primark Separation: Governance Reset or Value Catalyst?


Toyota Industries (6201 JP): Market Movements Support the Case of a Higher Offer

By Arun George

  • Last month, nearly two dozen global asset managers, through ACGA, submitted a joint letter to the boards of Toyota Industries (6201 JP) and Toyota Motor regarding the tender offer.
  • The letter outlined five issues, which distilled down to concerns about a low-balled offer. Their cause is increasingly supported by market movements, which support the case for the bump.
  • Recent activism against several low-balled tenders signals that TICO, despite its size, is not immune. My SoTP valuation is JPY19,607, which is 20.3% above the offer price.

StubWorld: Sumitomo Chemical/Sumitomo Pharma, Hyundai Motor/ Kia Corp, Ecopro Co/Ecopro BM

By David Blennerhassett

  • For a change of pace, this insight briefly canvasses a clutch of Holdco’s trading at extreme levels, in both “set-up” and “unwind” territory.
  • Preceding the chart/table-heavy insight are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

[Japan Activism] Mandom (4917 JP) – Murakami at 20% and Mandom Offers A Sweet Poison Pill

By Travis Lundy

  • Mandom Corp (4917 JP) yesterday decided to launch a question-response effort for the Murakami-san Group ownership of Mandom shares up to and above 20%. This is a Poison Pill precursor.
  • There’s a drawn out set of questions, answers, etc, at the end of which, the Independent Committee will decide that Murakami is a Bad Person and the Poison Pill proceeds.
  • Murakami Group is apparently now over 20%. That’s a little tricky. But this looks like a Good Poison Pill. 

Reading the Latest Flow Patterns to Time a SK Square NAV Squeeze Trade

By Sanghyun Park

  • Retail flow drove the ratio: selling pushed it higher, buying dragged it lower. Pre‑Sept they dip‑bought and flipped; since late Sept they’ve chased longs, fueling Hynix’s rally.
  • Instos joined retail chasing Hynix, juicing momentum; KRX’s investment‑alert acts as a speed bump, likely cooling hot‑money flows and tilting the ratio in Square’s favor.
  • But retail still drives Hynix; until they cool off, Square NAV squeeze is early. A sector‑wide AI pivot cooling retail frenzy is the real catalyst, bigger than KRX’s alert.

Physicswallah IPO: Index Inclusion Possibilities & Timing

By Brian Freitas

  • Physicswallah Limited (2076103D IN) is looking to list on the exchanges by selling 319.26m shares via a primary and secondary offering to raise US$392m at a valuation of US$3.5bn.
  • The price band has been set at INR 103-109/share, and the issue is likely to price at the top end of the range.
  • The stock will be added to the AMFI Smallcap segment and inclusion in the Nifty Smallcap 250 index is likely in March. Global index inclusion could commence in June.

Australia’s Big Banks: Options Flash Mixed Signals Ahead of Earnings

By Gaudenz Schneider

  • Australia’s largest banks are due to report within the next four trading days. Collectively, they account for 23% of the S&P/ASX 200 (AS51 INDEX).
  • A beat or miss of expectations can result in a strong move, up or down. This Insight analyzes options to provide an indication of how big a move to expect.
  • Option traders price in outsized moves for several but not all banks, with ANZ (ANZ AU) as the largest outlier.

ABF – Primark Separation: Governance Reset or Value Catalyst?

By Jesus Rodriguez Aguilar

  • ABF’s structural review could separate Primark from Food, unlocking value through clearer governance and capital allocation focus.
  • Our SOTP yields £26/share base case, implying ~17% upside to current price.
  • Event-Driven setup favours long ABF vs discretionary peers into April 2026 review conclusion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars